ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Breast Density As Important As Age In Determining Risk

September 29, 2006

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977